Agilent Life Sciences SS Tumor Map Assay Probe, DNA, 96A, EA
The Agilent SureSelect Tumor Map Assay Probe, DNA, 96A (part number 5191-7432) is designed for use in the SureSelect Tumor Map Assay, a targeted next-generation sequencing (NGS) solution for comprehensive tumor profiling. This probe set enables the capture and enrichment of specific genomic regions of interest from DNA samples, facilitating the detection of somatic mutations, copy number variations, and other genomic alterations relevant to cancer research. The product is optimized for high sensitivity and specificity, supporting robust performance in clinical research and translational oncology applications.